nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—CYP2A6—Prednisolone—psoriatic arthritis	0.132	0.183	CbGbCtD
Ifosfamide—CYP2A6—Dexamethasone—psoriatic arthritis	0.078	0.108	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0534	0.0737	CbGbCtD
Ifosfamide—CYP3A7—Dexamethasone—psoriatic arthritis	0.0534	0.0737	CbGbCtD
Ifosfamide—CYP2C19—Prednisone—psoriatic arthritis	0.0517	0.0715	CbGbCtD
Ifosfamide—CYP2B6—Dexamethasone—psoriatic arthritis	0.0508	0.0702	CbGbCtD
Ifosfamide—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0413	0.057	CbGbCtD
Ifosfamide—CYP3A5—Dexamethasone—psoriatic arthritis	0.04	0.0553	CbGbCtD
Ifosfamide—CYP2C8—Dexamethasone—psoriatic arthritis	0.0385	0.0532	CbGbCtD
Ifosfamide—CYP2C19—Dexamethasone—psoriatic arthritis	0.0323	0.0446	CbGbCtD
Ifosfamide—CYP3A4—Triamcinolone—psoriatic arthritis	0.0313	0.0432	CbGbCtD
Ifosfamide—CYP2C9—Dexamethasone—psoriatic arthritis	0.0268	0.0371	CbGbCtD
Ifosfamide—CYP3A4—Betamethasone—psoriatic arthritis	0.0268	0.0371	CbGbCtD
Ifosfamide—CYP3A4—Prednisolone—psoriatic arthritis	0.0265	0.0366	CbGbCtD
Ifosfamide—CYP3A4—Prednisone—psoriatic arthritis	0.025	0.0345	CbGbCtD
Ifosfamide—CYP3A4—Dexamethasone—psoriatic arthritis	0.0156	0.0216	CbGbCtD
Ifosfamide—Hypertension—Methylprednisolone—psoriatic arthritis	0.000295	0.00107	CcSEcCtD
Ifosfamide—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000294	0.00106	CcSEcCtD
Ifosfamide—Myalgia—Triamcinolone—psoriatic arthritis	0.000292	0.00106	CcSEcCtD
Ifosfamide—Pneumonia—Methotrexate—psoriatic arthritis	0.000291	0.00105	CcSEcCtD
Ifosfamide—Myalgia—Methylprednisolone—psoriatic arthritis	0.000291	0.00105	CcSEcCtD
Ifosfamide—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000291	0.00105	CcSEcCtD
Ifosfamide—Eye disorder—Prednisone—psoriatic arthritis	0.000291	0.00105	CcSEcCtD
Ifosfamide—Infestation NOS—Methotrexate—psoriatic arthritis	0.000289	0.00105	CcSEcCtD
Ifosfamide—Infestation—Methotrexate—psoriatic arthritis	0.000289	0.00105	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000289	0.00105	CcSEcCtD
Ifosfamide—Flushing—Prednisone—psoriatic arthritis	0.000289	0.00104	CcSEcCtD
Ifosfamide—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000288	0.00104	CcSEcCtD
Ifosfamide—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000288	0.00104	CcSEcCtD
Ifosfamide—Discomfort—Triamcinolone—psoriatic arthritis	0.000288	0.00104	CcSEcCtD
Ifosfamide—Discomfort—Methylprednisolone—psoriatic arthritis	0.000288	0.00104	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000287	0.00104	CcSEcCtD
Ifosfamide—Renal failure—Methotrexate—psoriatic arthritis	0.000285	0.00103	CcSEcCtD
Ifosfamide—Angioedema—Dexamethasone—psoriatic arthritis	0.000284	0.00103	CcSEcCtD
Ifosfamide—Angioedema—Betamethasone—psoriatic arthritis	0.000284	0.00103	CcSEcCtD
Ifosfamide—Stomatitis—Methotrexate—psoriatic arthritis	0.000282	0.00102	CcSEcCtD
Ifosfamide—Angiopathy—Prednisone—psoriatic arthritis	0.000282	0.00102	CcSEcCtD
Ifosfamide—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000281	0.00102	CcSEcCtD
Ifosfamide—Confusional state—Methylprednisolone—psoriatic arthritis	0.000281	0.00102	CcSEcCtD
Ifosfamide—Immune system disorder—Prednisone—psoriatic arthritis	0.000281	0.00102	CcSEcCtD
Ifosfamide—Malaise—Betamethasone—psoriatic arthritis	0.00028	0.00101	CcSEcCtD
Ifosfamide—Malaise—Dexamethasone—psoriatic arthritis	0.00028	0.00101	CcSEcCtD
Ifosfamide—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00028	0.00101	CcSEcCtD
Ifosfamide—Oedema—Triamcinolone—psoriatic arthritis	0.00028	0.00101	CcSEcCtD
Ifosfamide—Vertigo—Betamethasone—psoriatic arthritis	0.000279	0.00101	CcSEcCtD
Ifosfamide—Vertigo—Dexamethasone—psoriatic arthritis	0.000279	0.00101	CcSEcCtD
Ifosfamide—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000279	0.00101	CcSEcCtD
Ifosfamide—Arrhythmia—Prednisone—psoriatic arthritis	0.000278	0.00101	CcSEcCtD
Ifosfamide—Infection—Triamcinolone—psoriatic arthritis	0.000278	0.00101	CcSEcCtD
Ifosfamide—Infection—Methylprednisolone—psoriatic arthritis	0.000277	0.001	CcSEcCtD
Ifosfamide—Haematuria—Methotrexate—psoriatic arthritis	0.000276	0.000999	CcSEcCtD
Ifosfamide—Alopecia—Prednisone—psoriatic arthritis	0.000275	0.000994	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000274	0.000991	CcSEcCtD
Ifosfamide—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000274	0.00099	CcSEcCtD
Ifosfamide—Paraesthesia—Prednisolone—psoriatic arthritis	0.000273	0.000988	CcSEcCtD
Ifosfamide—Mental disorder—Prednisone—psoriatic arthritis	0.000272	0.000986	CcSEcCtD
Ifosfamide—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000271	0.000981	CcSEcCtD
Ifosfamide—Malnutrition—Prednisone—psoriatic arthritis	0.000271	0.00098	CcSEcCtD
Ifosfamide—Erythema—Prednisone—psoriatic arthritis	0.000271	0.00098	CcSEcCtD
Ifosfamide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00027	0.000978	CcSEcCtD
Ifosfamide—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00027	0.000978	CcSEcCtD
Ifosfamide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00027	0.000976	CcSEcCtD
Ifosfamide—Convulsion—Dexamethasone—psoriatic arthritis	0.000269	0.000975	CcSEcCtD
Ifosfamide—Convulsion—Betamethasone—psoriatic arthritis	0.000269	0.000975	CcSEcCtD
Ifosfamide—Hypertension—Betamethasone—psoriatic arthritis	0.000268	0.000971	CcSEcCtD
Ifosfamide—Hypertension—Dexamethasone—psoriatic arthritis	0.000268	0.000971	CcSEcCtD
Ifosfamide—Myalgia—Betamethasone—psoriatic arthritis	0.000265	0.000958	CcSEcCtD
Ifosfamide—Myalgia—Dexamethasone—psoriatic arthritis	0.000265	0.000958	CcSEcCtD
Ifosfamide—Discomfort—Dexamethasone—psoriatic arthritis	0.000261	0.000946	CcSEcCtD
Ifosfamide—Discomfort—Betamethasone—psoriatic arthritis	0.000261	0.000946	CcSEcCtD
Ifosfamide—Haemoglobin—Methotrexate—psoriatic arthritis	0.000261	0.000945	CcSEcCtD
Ifosfamide—Hypotension—Methylprednisolone—psoriatic arthritis	0.000261	0.000943	CcSEcCtD
Ifosfamide—Pain—Prednisolone—psoriatic arthritis	0.00026	0.000941	CcSEcCtD
Ifosfamide—Hepatitis—Methotrexate—psoriatic arthritis	0.00026	0.000941	CcSEcCtD
Ifosfamide—Haemorrhage—Methotrexate—psoriatic arthritis	0.00026	0.000941	CcSEcCtD
Ifosfamide—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000257	0.000929	CcSEcCtD
Ifosfamide—Vision blurred—Prednisone—psoriatic arthritis	0.000255	0.000923	CcSEcCtD
Ifosfamide—Urethral disorder—Methotrexate—psoriatic arthritis	0.000255	0.000922	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000255	0.000922	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000254	0.00092	CcSEcCtD
Ifosfamide—Oedema—Betamethasone—psoriatic arthritis	0.000254	0.000918	CcSEcCtD
Ifosfamide—Oedema—Dexamethasone—psoriatic arthritis	0.000254	0.000918	CcSEcCtD
Ifosfamide—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000254	0.000918	CcSEcCtD
Ifosfamide—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000254	0.000918	CcSEcCtD
Ifosfamide—Infection—Dexamethasone—psoriatic arthritis	0.000252	0.000912	CcSEcCtD
Ifosfamide—Infection—Betamethasone—psoriatic arthritis	0.000252	0.000912	CcSEcCtD
Ifosfamide—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000251	0.000909	CcSEcCtD
Ifosfamide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000251	0.000909	CcSEcCtD
Ifosfamide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000251	0.000907	CcSEcCtD
Ifosfamide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00025	0.000907	CcSEcCtD
Ifosfamide—Visual impairment—Methotrexate—psoriatic arthritis	0.00025	0.000906	CcSEcCtD
Ifosfamide—Anaemia—Prednisone—psoriatic arthritis	0.00025	0.000905	CcSEcCtD
Ifosfamide—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000249	0.000902	CcSEcCtD
Ifosfamide—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000249	0.0009	CcSEcCtD
Ifosfamide—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000249	0.0009	CcSEcCtD
Ifosfamide—Agitation—Prednisone—psoriatic arthritis	0.000249	0.0009	CcSEcCtD
Ifosfamide—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000248	0.000899	CcSEcCtD
Ifosfamide—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000248	0.000899	CcSEcCtD
Ifosfamide—Angioedema—Prednisone—psoriatic arthritis	0.000247	0.000895	CcSEcCtD
Ifosfamide—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000246	0.000889	CcSEcCtD
Ifosfamide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000245	0.000888	CcSEcCtD
Ifosfamide—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000245	0.000888	CcSEcCtD
Ifosfamide—Malaise—Prednisone—psoriatic arthritis	0.000244	0.000883	CcSEcCtD
Ifosfamide—Vertigo—Prednisone—psoriatic arthritis	0.000243	0.00088	CcSEcCtD
Ifosfamide—Eye disorder—Methotrexate—psoriatic arthritis	0.000243	0.000879	CcSEcCtD
Ifosfamide—Tinnitus—Methotrexate—psoriatic arthritis	0.000242	0.000877	CcSEcCtD
Ifosfamide—Anorexia—Betamethasone—psoriatic arthritis	0.000242	0.000875	CcSEcCtD
Ifosfamide—Anorexia—Dexamethasone—psoriatic arthritis	0.000242	0.000875	CcSEcCtD
Ifosfamide—Urticaria—Prednisolone—psoriatic arthritis	0.000242	0.000874	CcSEcCtD
Ifosfamide—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000241	0.000873	CcSEcCtD
Ifosfamide—Fatigue—Triamcinolone—psoriatic arthritis	0.000241	0.000872	CcSEcCtD
Ifosfamide—Fatigue—Methylprednisolone—psoriatic arthritis	0.000241	0.00087	CcSEcCtD
Ifosfamide—Pain—Triamcinolone—psoriatic arthritis	0.000239	0.000865	CcSEcCtD
Ifosfamide—Hypotension—Betamethasone—psoriatic arthritis	0.000237	0.000858	CcSEcCtD
Ifosfamide—Hypotension—Dexamethasone—psoriatic arthritis	0.000237	0.000858	CcSEcCtD
Ifosfamide—Angiopathy—Methotrexate—psoriatic arthritis	0.000236	0.000853	CcSEcCtD
Ifosfamide—Immune system disorder—Methotrexate—psoriatic arthritis	0.000235	0.00085	CcSEcCtD
Ifosfamide—Convulsion—Prednisone—psoriatic arthritis	0.000235	0.000849	CcSEcCtD
Ifosfamide—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000234	0.000848	CcSEcCtD
Ifosfamide—Hypertension—Prednisone—psoriatic arthritis	0.000234	0.000846	CcSEcCtD
Ifosfamide—Chills—Methotrexate—psoriatic arthritis	0.000233	0.000844	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000231	0.000836	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000231	0.000836	CcSEcCtD
Ifosfamide—Arthralgia—Prednisone—psoriatic arthritis	0.00023	0.000834	CcSEcCtD
Ifosfamide—Myalgia—Prednisone—psoriatic arthritis	0.00023	0.000834	CcSEcCtD
Ifosfamide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00023	0.000834	CcSEcCtD
Ifosfamide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00023	0.000832	CcSEcCtD
Ifosfamide—Alopecia—Methotrexate—psoriatic arthritis	0.00023	0.000831	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000229	0.000828	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000228	0.000826	CcSEcCtD
Ifosfamide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000228	0.000824	CcSEcCtD
Ifosfamide—Paraesthesia—Betamethasone—psoriatic arthritis	0.000228	0.000824	CcSEcCtD
Ifosfamide—Discomfort—Prednisone—psoriatic arthritis	0.000228	0.000824	CcSEcCtD
Ifosfamide—Mental disorder—Methotrexate—psoriatic arthritis	0.000228	0.000824	CcSEcCtD
Ifosfamide—Malnutrition—Methotrexate—psoriatic arthritis	0.000226	0.000819	CcSEcCtD
Ifosfamide—Erythema—Methotrexate—psoriatic arthritis	0.000226	0.000819	CcSEcCtD
Ifosfamide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000224	0.000811	CcSEcCtD
Ifosfamide—Urticaria—Triamcinolone—psoriatic arthritis	0.000222	0.000804	CcSEcCtD
Ifosfamide—Urticaria—Methylprednisolone—psoriatic arthritis	0.000222	0.000802	CcSEcCtD
Ifosfamide—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000221	0.0008	CcSEcCtD
Ifosfamide—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000221	0.0008	CcSEcCtD
Ifosfamide—Oedema—Prednisone—psoriatic arthritis	0.000221	0.0008	CcSEcCtD
Ifosfamide—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000221	0.000798	CcSEcCtD
Ifosfamide—Decreased appetite—Betamethasone—psoriatic arthritis	0.000221	0.000798	CcSEcCtD
Ifosfamide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000221	0.000798	CcSEcCtD
Ifosfamide—Infection—Prednisone—psoriatic arthritis	0.000219	0.000794	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000219	0.000793	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000219	0.000793	CcSEcCtD
Ifosfamide—Fatigue—Dexamethasone—psoriatic arthritis	0.000219	0.000792	CcSEcCtD
Ifosfamide—Fatigue—Betamethasone—psoriatic arthritis	0.000219	0.000792	CcSEcCtD
Ifosfamide—Pain—Dexamethasone—psoriatic arthritis	0.000217	0.000785	CcSEcCtD
Ifosfamide—Pain—Betamethasone—psoriatic arthritis	0.000217	0.000785	CcSEcCtD
Ifosfamide—Nervous system disorder—Prednisone—psoriatic arthritis	0.000217	0.000784	CcSEcCtD
Ifosfamide—Skin disorder—Prednisone—psoriatic arthritis	0.000215	0.000777	CcSEcCtD
Ifosfamide—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000214	0.000773	CcSEcCtD
Ifosfamide—Vision blurred—Methotrexate—psoriatic arthritis	0.000213	0.000772	CcSEcCtD
Ifosfamide—Anorexia—Prednisone—psoriatic arthritis	0.000211	0.000762	CcSEcCtD
Ifosfamide—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00021	0.00076	CcSEcCtD
Ifosfamide—Anaemia—Methotrexate—psoriatic arthritis	0.000209	0.000757	CcSEcCtD
Ifosfamide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000209	0.000757	CcSEcCtD
Ifosfamide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000209	0.000757	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000207	0.000751	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000207	0.000751	CcSEcCtD
Ifosfamide—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000206	0.000745	CcSEcCtD
Ifosfamide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000206	0.000744	CcSEcCtD
Ifosfamide—Malaise—Methotrexate—psoriatic arthritis	0.000204	0.000738	CcSEcCtD
Ifosfamide—Vertigo—Methotrexate—psoriatic arthritis	0.000203	0.000736	CcSEcCtD
Ifosfamide—Leukopenia—Methotrexate—psoriatic arthritis	0.000202	0.000733	CcSEcCtD
Ifosfamide—Urticaria—Dexamethasone—psoriatic arthritis	0.000202	0.000729	CcSEcCtD
Ifosfamide—Urticaria—Betamethasone—psoriatic arthritis	0.000202	0.000729	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000201	0.000728	CcSEcCtD
Ifosfamide—Dizziness—Prednisolone—psoriatic arthritis	0.000201	0.000728	CcSEcCtD
Ifosfamide—Asthenia—Triamcinolone—psoriatic arthritis	0.000201	0.000726	CcSEcCtD
Ifosfamide—Body temperature increased—Betamethasone—psoriatic arthritis	0.000201	0.000726	CcSEcCtD
Ifosfamide—Abdominal pain—Betamethasone—psoriatic arthritis	0.000201	0.000726	CcSEcCtD
Ifosfamide—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000201	0.000726	CcSEcCtD
Ifosfamide—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000201	0.000726	CcSEcCtD
Ifosfamide—Asthenia—Methylprednisolone—psoriatic arthritis	0.0002	0.000724	CcSEcCtD
Ifosfamide—Paraesthesia—Prednisone—psoriatic arthritis	0.000198	0.000718	CcSEcCtD
Ifosfamide—Pruritus—Triamcinolone—psoriatic arthritis	0.000198	0.000716	CcSEcCtD
Ifosfamide—Cough—Methotrexate—psoriatic arthritis	0.000197	0.000714	CcSEcCtD
Ifosfamide—Pruritus—Methylprednisolone—psoriatic arthritis	0.000197	0.000714	CcSEcCtD
Ifosfamide—Convulsion—Methotrexate—psoriatic arthritis	0.000196	0.000709	CcSEcCtD
Ifosfamide—Chest pain—Methotrexate—psoriatic arthritis	0.000193	0.000697	CcSEcCtD
Ifosfamide—Arthralgia—Methotrexate—psoriatic arthritis	0.000193	0.000697	CcSEcCtD
Ifosfamide—Myalgia—Methotrexate—psoriatic arthritis	0.000193	0.000697	CcSEcCtD
Ifosfamide—Decreased appetite—Prednisone—psoriatic arthritis	0.000192	0.000695	CcSEcCtD
Ifosfamide—Rash—Prednisolone—psoriatic arthritis	0.000192	0.000694	CcSEcCtD
Ifosfamide—Dermatitis—Prednisolone—psoriatic arthritis	0.000192	0.000693	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000191	0.000692	CcSEcCtD
Ifosfamide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000191	0.000691	CcSEcCtD
Ifosfamide—Fatigue—Prednisone—psoriatic arthritis	0.00019	0.000689	CcSEcCtD
Ifosfamide—Discomfort—Methotrexate—psoriatic arthritis	0.00019	0.000689	CcSEcCtD
Ifosfamide—Constipation—Prednisone—psoriatic arthritis	0.000189	0.000684	CcSEcCtD
Ifosfamide—Confusional state—Methotrexate—psoriatic arthritis	0.000186	0.000674	CcSEcCtD
Ifosfamide—Dizziness—Triamcinolone—psoriatic arthritis	0.000185	0.000669	CcSEcCtD
Ifosfamide—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000185	0.000668	CcSEcCtD
Ifosfamide—Dizziness—Methylprednisolone—psoriatic arthritis	0.000184	0.000668	CcSEcCtD
Ifosfamide—Infection—Methotrexate—psoriatic arthritis	0.000183	0.000664	CcSEcCtD
Ifosfamide—Feeling abnormal—Prednisone—psoriatic arthritis	0.000182	0.000659	CcSEcCtD
Ifosfamide—Asthenia—Betamethasone—psoriatic arthritis	0.000182	0.000659	CcSEcCtD
Ifosfamide—Asthenia—Dexamethasone—psoriatic arthritis	0.000182	0.000659	CcSEcCtD
Ifosfamide—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000181	0.000655	CcSEcCtD
Ifosfamide—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000181	0.000654	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000181	0.000654	CcSEcCtD
Ifosfamide—Nausea—Prednisolone—psoriatic arthritis	0.000181	0.000654	CcSEcCtD
Ifosfamide—Pruritus—Dexamethasone—psoriatic arthritis	0.000179	0.00065	CcSEcCtD
Ifosfamide—Pruritus—Betamethasone—psoriatic arthritis	0.000179	0.00065	CcSEcCtD
Ifosfamide—Skin disorder—Methotrexate—psoriatic arthritis	0.000179	0.000649	CcSEcCtD
Ifosfamide—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000178	0.000646	CcSEcCtD
Ifosfamide—Vomiting—Triamcinolone—psoriatic arthritis	0.000178	0.000643	CcSEcCtD
Ifosfamide—Vomiting—Methylprednisolone—psoriatic arthritis	0.000177	0.000642	CcSEcCtD
Ifosfamide—Rash—Triamcinolone—psoriatic arthritis	0.000176	0.000638	CcSEcCtD
Ifosfamide—Dermatitis—Triamcinolone—psoriatic arthritis	0.000176	0.000637	CcSEcCtD
Ifosfamide—Anorexia—Methotrexate—psoriatic arthritis	0.000176	0.000637	CcSEcCtD
Ifosfamide—Rash—Methylprednisolone—psoriatic arthritis	0.000176	0.000637	CcSEcCtD
Ifosfamide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000176	0.000636	CcSEcCtD
Ifosfamide—Urticaria—Prednisone—psoriatic arthritis	0.000176	0.000635	CcSEcCtD
Ifosfamide—Body temperature increased—Prednisone—psoriatic arthritis	0.000175	0.000632	CcSEcCtD
Ifosfamide—Abdominal pain—Prednisone—psoriatic arthritis	0.000175	0.000632	CcSEcCtD
Ifosfamide—Diarrhoea—Betamethasone—psoriatic arthritis	0.000174	0.000628	CcSEcCtD
Ifosfamide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000174	0.000628	CcSEcCtD
Ifosfamide—Hypotension—Methotrexate—psoriatic arthritis	0.000173	0.000624	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000168	0.000609	CcSEcCtD
Ifosfamide—Dizziness—Betamethasone—psoriatic arthritis	0.000168	0.000607	CcSEcCtD
Ifosfamide—Dizziness—Dexamethasone—psoriatic arthritis	0.000168	0.000607	CcSEcCtD
Ifosfamide—Nausea—Triamcinolone—psoriatic arthritis	0.000166	0.000601	CcSEcCtD
Ifosfamide—Paraesthesia—Methotrexate—psoriatic arthritis	0.000166	0.0006	CcSEcCtD
Ifosfamide—Nausea—Methylprednisolone—psoriatic arthritis	0.000166	0.0006	CcSEcCtD
Ifosfamide—Dyspnoea—Methotrexate—psoriatic arthritis	0.000165	0.000596	CcSEcCtD
Ifosfamide—Somnolence—Methotrexate—psoriatic arthritis	0.000164	0.000594	CcSEcCtD
Ifosfamide—Hypersensitivity—Prednisone—psoriatic arthritis	0.000163	0.000589	CcSEcCtD
Ifosfamide—Vomiting—Betamethasone—psoriatic arthritis	0.000161	0.000584	CcSEcCtD
Ifosfamide—Vomiting—Dexamethasone—psoriatic arthritis	0.000161	0.000584	CcSEcCtD
Ifosfamide—Decreased appetite—Methotrexate—psoriatic arthritis	0.00016	0.000581	CcSEcCtD
Ifosfamide—Rash—Dexamethasone—psoriatic arthritis	0.00016	0.000579	CcSEcCtD
Ifosfamide—Rash—Betamethasone—psoriatic arthritis	0.00016	0.000579	CcSEcCtD
Ifosfamide—Dermatitis—Dexamethasone—psoriatic arthritis	0.00016	0.000578	CcSEcCtD
Ifosfamide—Dermatitis—Betamethasone—psoriatic arthritis	0.00016	0.000578	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000159	0.000577	CcSEcCtD
Ifosfamide—Fatigue—Methotrexate—psoriatic arthritis	0.000159	0.000576	CcSEcCtD
Ifosfamide—Asthenia—Prednisone—psoriatic arthritis	0.000159	0.000574	CcSEcCtD
Ifosfamide—Pain—Methotrexate—psoriatic arthritis	0.000158	0.000571	CcSEcCtD
Ifosfamide—Pruritus—Prednisone—psoriatic arthritis	0.000156	0.000566	CcSEcCtD
Ifosfamide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000152	0.000551	CcSEcCtD
Ifosfamide—Diarrhoea—Prednisone—psoriatic arthritis	0.000151	0.000547	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000151	0.000546	CcSEcCtD
Ifosfamide—Nausea—Betamethasone—psoriatic arthritis	0.000151	0.000545	CcSEcCtD
Ifosfamide—Nausea—Dexamethasone—psoriatic arthritis	0.000151	0.000545	CcSEcCtD
Ifosfamide—Urticaria—Methotrexate—psoriatic arthritis	0.000147	0.000531	CcSEcCtD
Ifosfamide—Dizziness—Prednisone—psoriatic arthritis	0.000146	0.000529	CcSEcCtD
Ifosfamide—Body temperature increased—Methotrexate—psoriatic arthritis	0.000146	0.000528	CcSEcCtD
Ifosfamide—Abdominal pain—Methotrexate—psoriatic arthritis	0.000146	0.000528	CcSEcCtD
Ifosfamide—Vomiting—Prednisone—psoriatic arthritis	0.00014	0.000508	CcSEcCtD
Ifosfamide—Rash—Prednisone—psoriatic arthritis	0.000139	0.000504	CcSEcCtD
Ifosfamide—Dermatitis—Prednisone—psoriatic arthritis	0.000139	0.000504	CcSEcCtD
Ifosfamide—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000136	0.000492	CcSEcCtD
Ifosfamide—Asthenia—Methotrexate—psoriatic arthritis	0.000132	0.000479	CcSEcCtD
Ifosfamide—Nausea—Prednisone—psoriatic arthritis	0.000131	0.000475	CcSEcCtD
Ifosfamide—Pruritus—Methotrexate—psoriatic arthritis	0.000131	0.000473	CcSEcCtD
Ifosfamide—Diarrhoea—Methotrexate—psoriatic arthritis	0.000126	0.000457	CcSEcCtD
Ifosfamide—Dizziness—Methotrexate—psoriatic arthritis	0.000122	0.000442	CcSEcCtD
Ifosfamide—Vomiting—Methotrexate—psoriatic arthritis	0.000117	0.000425	CcSEcCtD
Ifosfamide—Rash—Methotrexate—psoriatic arthritis	0.000116	0.000421	CcSEcCtD
Ifosfamide—Dermatitis—Methotrexate—psoriatic arthritis	0.000116	0.000421	CcSEcCtD
Ifosfamide—Nausea—Methotrexate—psoriatic arthritis	0.00011	0.000397	CcSEcCtD
